Thursday’s Daily Piece: Canagliflozin Loses Leg and Foot Amputation Boxed Warning

Well, a new bright day has dawned for canagliflozin. Canagliflozin has had a boxed warning for leg and foot amputations. FDA review of new data from three clinical trials resulted in the removal of the boxed warning for leg and foot amputations. Additionally, canagliflozin is now recognized for its heart and kidney related benefits. To learn more, please click on the link below.

https://www.fda.gov/safety/medical-product-safety-information/invokana-invokamet-invokamet-xr-canagliflozin-medwatch-safety-alert-boxed-warning-about-risk-leg-and

INVOKANA® (canagliflozin) Significantly Reduced Major Cardiovascular Events  and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney  Disease – Intelligence Pharma
This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#canagliflozin #FDA

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.

2 Replies to “Thursday’s Daily Piece: Canagliflozin Loses Leg and Foot Amputation Boxed Warning”

  1. Hey, I was wondering if you have heard of this Diabetes program before? https://bit.ly/3jovGfx
    It looks like a great program to help people. I was just looking for some options before I made my decision. By the way, I Love the content you have been posting lately

    1. Hi Rebecca, it looks like an interesting program although I am always hesitate to recommend programs such as this one which make big promises without having lots of information. Thank you so much for your positive feedback.

Leave a Reply

Your email address will not be published. Required fields are marked *